How one program saved 1 insurer $20M
(By Rylee Wilson for Becker’s Hospital Review) A diabetes management program has saved Capital Blue Cross employer group customers $20
Read More
Part D/Prescription Drugs
Biden-Harris Administration Announces Medicare Advantage and Medicare Part D Prescription Drug Proposals that Aim to Improve Care and Access for Enrollees
Press Release from hhs.gov on November 26, 2024 Today, the Centers for Medicare & Medicaid Services (CMS) is proposing actions
Read MoreOzempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
By Greg Norman for Fox News on November 26, 2024 The Biden administration is expanding coverage of anti-obesity drugs such as Ozempic
Read MoreThis retirement expert saved her mom $1,200 on Medicare drugs, says older people are ‘getting screwed’ — here are 3 of her tips to cut your health care costs ASAP
By Christy Bieber for Moneywise on November 23, 2024 Hindsight is 20-20, but for one 85-year-old retiree, the discovery that
Read MoreFlorida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval
(By Phil Galewitz for KFF Health News) Nearly a year after the Biden administration gave Florida the green light to
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(Juliette Cubanski for The Kaiser Family Foundation Published: Nov 19, 2024) The Inflation Reduction Act of 2022 (the Act), signed
Read MoreUS News names top Medicare Advantage, Part D providers for 2025
(By Kelly Gooch for Becker’s Hospital Review) U.S. News & World Report has recognized seven Medicare Advantage and Medicare Part
Read MoreAfter retail pharmacy closures, health systems enter new markets
(By Paige Twenter for Becker’s Hospital Review) As CVS, Walgreens and Rite Aid close hundreds of pharmacies across the U.S.
Read MoreDrugmakers and pharmacists battle over who gets to make obesity drugs
(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read MoreFuture of Medicare drug price negotiations under new administration: 5 things to know
(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More